• RSS
  • Twitter
  • FaceBook
Home > White Papers > Cymfony > Pharmaceutical Social Media Marketing: Risks and Regulatory Issues

Pharmaceutical Social Media Marketing: Risks and Regulatory Issues

Cymfony

The pharmaceutical industry is very interested in using social media to promote products, services and issues important to it. However, many drug firm executives are uncertain about how to tackle the legal and regulatory issues associated with social media communications.

Email this page
Published:  Sep 13, 2007
Length:  27
Type:  White Paper
Tags : 
health, healthcare, pharmaceuticals, pharmaceutical, social media, fda, compliance, cymfony, best practices, business intelligence, marketing automation, sales automation



Community Area

Log in | Register

Solution Center

Follow TechGenix on Twitter